Game Review: Spore
Spore is a really in depth game, it contains several different genres of gameplay and appeals to all ages. Some parts can be rather repetetive and ...
Mount & Blade: With Fire and Sword Game Review
www.amazon.com Mount and Blade: With Fire and Sword is the fun and competitive third installment in the Mount and Blade series. Although it often ...
"Sitting Ducks" No Longer: Advance Flu Warning Permits Creation of Replikins ...
/PRNewswire/ -- Animals and humans no longer need to be "sitting ducks," oblivious to and unprepared for emergent infectious disease outbreaks. Rather than being caught off-guard by mass influenza outbreaks, UK-based biotech firm BioRadar Ltd. can successfully analyze the concentration and structure of the genomic Replikins in 'scout' viruses isolated from initial cases up to one year or longer, which provides advance warning of, and the ability to respond to the coming specific outbreaks (1,2).
(Photo: http://photos.prnewswire.com/prnh/20111110/NY04916 )
More significantly, the advance warning affords BioRadar the time to produce specific solid-phase synthetic Replikins vaccines in seven days, and to test them thoroughly. Bulk production also takes days rather than months. Storage does not require refrigeration. For an example of current advance warning in H5N1 influenza, see Figure.
Specifically, BioRadar UK Ltd will make available the following synthetic updated Bogoch Replikins vaccines for animals: ReplikinsTransFlu™ against H5N1-H9N2-H1N1 Influenza Viruses in Poultry; ReplikinsFMD™ against Foot and Mouth Disease Virus in Livestock; ReplikinsTaura™ against Taura Syndrome Virus in Shrimp; and ReplikinsAMD™ against Aleutian Mink Disease Virus in mink.
Advanced article Food Trade Review News
|
"Sitting Ducks" No Longer: Advance Flu Warning Permits Creation of Replikins ... DVM Newsmagazine, UN Food and Agriculture Organization (FAO) discussion of Replikins. September 8, 2011 Replikins Press Reports, No. 35. UK Trade and Investment article. BioRadar to set up HQ in Britain. March 25, 2010 Reader comments on Sacbee.com are ... |
|
Cardium Presents Third Quarter 2011 Financial Results and Reports on Near-Term ... Cardium's Excellagen fibrillar collagen topical gel also represents a new product platform that allows for the potential development of a portfolio of advanced wound care and therapeutic products. Cardium's Gene Activated Matrix (GAM) technology ... |
|
New Jersey Health Foundation Receives $1 Million Endowment From Wakefern Food ... 9, 2011 -- /PRNewswire-USNewswire/ -- New Jersey Health Foundation and its affiliate, the Foundation of UMDNJ, have received a $1 million gift from Wakefern Food Corp. to establish The Dean Janeway Endowment to Advance Healthcare Excellence. ... |
|
Guided Therapeutics Reports Update on FDA Review of LuViva™ Advanced Cervical ... Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP) today announced the US Food and Drug Administration (FDA) has informed the company that the agency is not planning a panel review to render a decision on the Premarket Approval (PMA) application of the ... |
Curis says health regulators grant priority review for cancer drug
Curis chief executive Dan Passeri said: "We are extremely pleased that the FDA has accepted the vismodegib NDA for review and that the submission will receive priority review. “With no currently approved treatments for advanced basal cell carcinoma, ...
|